Puerarin improves skeletal muscle strength by regulating gut microbiota in young adult rats

Wenyao Yang; Bimin Gao; Ling Qin; Xinluan Wang

doi:10.1016/j.jot.2022.08.009

Puerarin improves skeletal muscle strength by regulating gut microbiota in young adult rats

J Orthop Translat. 2022 Sep 21:35:87-98. doi: 10.1016/j.jot.2022.08.009. eCollection 2022 Jul.

Authors

Wenyao Yang^{1

2}, Bimin Gao^{1

2}, Ling Qin^{1

3

2}, Xinluan Wang^{1

2}

Affiliations

¹ Translational Medicine R&D Center, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
² Joint Laboratory of Chinese Academic of Science and Hong Kong for Biomaterials of the Chinese University of Hong Kong, Shenzhen, China.
³ Musculoskeletal Research Laboratory, Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong, China.

Abstract

Background: Sarcopenia is an age-related skeletal muscle dysfunction syndrome that is lacking validated treatments. Maximizing muscle strength in young adulthood may be a promising way to prevent sarcopenia in the elderly. The phytomolecule puerarin has been extensively used in clinical practice and reported to increase energy metabolism in skeletal muscle by directly targeting the skeletal muscle fiber. However, the bioavailability of puerarin is very poor, and almost 93% of puerarin stays in the intestine until excretion. Therefore, we hypothesize that puerarin may regulate gut microbiota to improve skeletal muscle strength and/or mass in adults.

Methods: Twenty three-month old male Sprague Dawley rats were divided into two groups according to average weights, puerarin group (puerarin dissolved in 0.5% CMC-Na, 150 mg/kg/day, N = 10), and control group (equal volume 0.5% CMC-Na, N = 10). The treatment lasted for 8 weeks. Muscle weight, muscle fiber types and cross-sectional area (CSA), ex vivo muscle contraction test and grip strength were measured. 16S rDNA sequencing was employed to evaluate the gut microbiota composition in the sample of cecal content. Short-chain fatty acids (SCFAs) in cecal and serum were analyzed by gas chromatography-mass spectrometry. Adenosine triphosphate (ATP) concentration in skeletal muscle was also detected. Pearson's correlation was used to analyze the relations between SCFAs, ATP concentration and muscle function.

Results: After puerarin treatment, grip strength, the specific twitch force, and the tetanic forces in the soleus (SOL) and extensor digitorum longus (EDL) muscle were significantly higher than those of the control group. The percentage and CSA of type II muscle fiber in EDL was higher in the puerarin group than those in the control group. Puerarin treatment significantly changed the gut microbial constitutes. Two SCFAs-productive microbiota, the families Peptococcaceae and Closteridiales, were significantly higher in the puerarin group than those in the control group, while the ratio of Prevotellaceae/Bacteroidaceae (P/B), a muscle atrophy indicator, was lower in the puerarin group. As expected, there were significant linear correlations between the concentrations of SCFAs, including cecal total SCFAs, serum n-butyric acid and total SCFAs, and skeletal muscle strength and function, including the twitch force and tetanic force of SOL and EDL, as well as the forelimb grip strength.

Conclusion: In conclusion, puerarin improved the forelimb grip strength and muscle contraction function in young adult rats. The underlying mechanism may include that puerarin increased SCFAs production by regulating gut microbiota, augmented ATP synthesis and skeletal muscle strength. The translational potential of this article : Our study finds that a clinical used phytomolecule puerarin has the potential of improving skeletal muscle strength in young adult rats. As puerarin has long-term clinical experience and shows good safety, it might be a potential candidate for developing muscle strengthening agents.

Keywords: ATP, adenosine triphosphate; CMC-Na, sodium carboxymethyl cellulose; CSA, cross-sectional area; EDL, extensor digitorum longus; GC–MS, gas chromatography-mass spectrometry; Gut microbiota; Puerarin; SCFAs; SCFAs, short-chain fatty acids; SOL, soleus; Skeletal muscle.